UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000039155
Receipt No. R000044657
Scientific Title Fpllow-up study of multicenter, prospective, randomised and comparative study of alternative anti-androgen (AA) therapy and early initiating enzalutamide for castration-resistant prostate cancer (CRPC) after combined androgen blockade (CAB) therapy with bicalutamide (OCUU-CRPC follow-up study).
Date of disclosure of the study information 2020/01/21
Last modified on 2021/10/07 14:59:30

No. Disposal Last modified on Item of update
1 Insert 2020/01/14 17:32:32
2 Update 2020/01/23 10:25:50 Key secondary outcomes
Key secondary outcomes
3 Update 2020/07/16 16:41:02 Key inclusion criteria
Key inclusion criteria
Target sample size
4 Update 2020/07/16 16:41:45 Number of participants that the trial has enrolled
5 Update 2021/07/19 12:03:44 Last follow-up date
Date analysis concluded
6 Update 2021/10/07 14:59:30 Date of closure to data entry
Date trial data considered complete

Contact us.